Cargando…

Case report and literature review: PET/CT in the evaluation of response to treatment of liver metastasis from colorectal cancer with DEBIRI-TACE

BACKGROUND: Irinotecan-loaded drug-eluting beads transarterial chemoembolization (DEBIRI-TACE) is a safe and effective therapeutic option for unresectable colorectal liver metastases (CRLM). The evaluation of treatment response after DEBIRI-TACE is very important for assessing the patient’s conditio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Lan, Hu, Wuyun, Li, Teng, Sun, Honghua, Kang, Dongxu, Piao, Longzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017836/ https://www.ncbi.nlm.nih.gov/pubmed/36937414 http://dx.doi.org/10.3389/fonc.2023.1015976

Ejemplares similares

The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
por: Vogl, Thomas J., et al.
Publicado: (2022)

Small Particle DEBIRI TACE as Salvage Therapy in Patients with Liver Dominant Colorectal Cancer Metastasis: Retrospective Analysis of Safety and Outcomes
por: Voizard, Nicolas, et al.
Publicado: (2022)

Case Report: PD-L1-negative advanced bladder cancer effectively treated with anlotinib and tislelizumab: A report of two cases
por: Li, Teng, et al.
Publicado: (2023)

Updates of colorectal cancer liver metastases therapy: review on DEBIRI
por: Fiorentini, Giammaria, et al.
Publicado: (2020)

Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer
por: Stutz, M., et al.
Publicado: (2015)

Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT
por: Zhou, Nina, et al.
Publicado: (2021)

First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI)
por: EICHLER, K., et al.
Publicado: (2012)

Automated segmentation of colorectal liver metastasis and liver ablation on contrast-enhanced CT images
por: Anderson, Brian M., et al.
Publicado: (2022)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
por: Yao, Wang, et al.
Publicado: (2020)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis
por: Li, Yue, et al.
Publicado: (2022)

Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry
por: Martin, Robert C. G., et al.
Publicado: (2009)

Literature Review of Current Management of Colorectal Liver Metastasis
por: Mitchell, Diana, et al.
Publicado: (2019)

Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management
por: Ahmed, Fatma, et al.
Publicado: (2016)

Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis
por: Peng, Honghua, et al.
Publicado: (2021)

Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection
por: Schnitzer, Moritz L., et al.
Publicado: (2023)

The Value of (18)F-FDG PET/CT and Abdominal PET/MRI as a One-Stop Protocol in Patients With Potentially Resectable Colorectal Liver Metastases
por: Zhou, Nina, et al.
Publicado: (2021)

Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case Reports
por: Tian, Yuan, et al.
Publicado: (2023)

Efficacy and Safety of TACE Combined with Regorafenib versus TACE in the Third-Line Treatment of Colorectal Liver Metastases
por: Lu, Haohao, et al.
Publicado: (2022)

Acute Kidney Injury in Adult Patients With Hepatocellular Carcinoma After TACE or Hepatectomy Treatment
por: Mou, Zhixiang, et al.
Publicado: (2022)

TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study
por: Yang, Biao, et al.
Publicado: (2021)

Tailoring the clinical management of colorectal cancer by (18)F-FDG PET/CT
por: Shi, Yang, et al.
Publicado: (2022)

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
por: Pernot, Simon, et al.
Publicado: (2020)

The (18)F-PSMA-1007 PET/CT performance on metastasis status and therapy assessment in oligo-metastasis prostate cancer
por: Wang, Zhuonan, et al.
Publicado: (2022)

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT
por: Huang, Wei, et al.
Publicado: (2022)

Quantitative Prediction of Microsatellite Instability in Colorectal Cancer With Preoperative PET/CT-Based Radiomics
por: Li, Jiaru, et al.
Publicado: (2021)

Efficacy and Safety of TACE Combined With Lenvatinib Plus PD-1 Inhibitors Compared With TACE Alone for Unresectable Hepatocellular Carcinoma Patients: A Prospective Cohort Study
por: Qu, Shuping, et al.
Publicado: (2022)

Down-Regulation of Collagen Hydroxylation in Colorectal Liver Metastasis
por: van Huizen, Nick A., et al.
Publicado: (2020)

Colorectal Cancer Stem Cells in the Progression to Liver Metastasis
por: Gonzalez-Villarreal, Carlos A., et al.
Publicado: (2020)

Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis
por: Wang, Yun, et al.
Publicado: (2022)

Prospective study of TACE combined with sorafenib vs TACE combined with (125)I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas
por: Zhao, Xiao-Hui, et al.
Publicado: (2022)

Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
por: Chang, Pi-Yi, et al.
Publicado: (2023)

Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?
por: Ge, Naijian, et al.
Publicado: (2023)

4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT
por: Chi, Alexander, et al.
Publicado: (2014)

Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma
por: Adwan, Hassan, et al.
Publicado: (2017)

Predictive value of intratumoral-metabolic heterogeneity derived from (18)F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
por: Zhang, Li, et al.
Publicado: (2023)

The role of PET/CT in cervical cancer
por: Herrera, Fernanda G., et al.
Publicado: (2013)

The Prognostic Value of (18)F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)
por: Ma, Wenhui, et al.
Publicado: (2014)

Average CT in PET studies of colorectal cancer patients with metastasis in the liver and esophageal cancer patients
por: Tonkopi, Elena, et al.
Publicado: (2010)

Ureteral metastasis in colorectal cancer: A case report and review of literature
por: Loloi, Justin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_66h0ckt37335kfdvtpcdp1nqa0